NGM · —
KEQU (KEQU) Stock
$36.40
+0.28%
NGM: KEQU
—
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
The Zacks Analyst Blog Highlights Eli Lilly, Costco Wholesale, Morgan Stanley and Kewaunee Scientific
Zacks · Jul 22, 2026
Top Research Reports for Eli Lilly, Costco & Morgan Stanley
Zacks · Jul 21, 2026
Kewaunee Scientific Q4 Earnings & Sales Fall Y/Y on Project Timing
Zacks · Jun 29, 2026
Kewaunee Scientific Fiscal Q4 Adjusted Earnings, Revenue Decline
MT Newswires · Jun 23, 2026
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter
PR Newswire · Jun 23, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held24.65%
Institutions Held41.62%
Institutions Float Held55.23%
Peer Comparison
About KEQU
KEQU is led by CEO Thomas David Hull, employs 1,006 people, headquartered in US, publicly traded since 1980.
KEQU stock trades at $36.40 with a market capitalization of $104.41M. The stock is valued at a price-to-earnings (P/E) ratio of 10.76, price-to-book of 1.85, price-to-sales of 0.41. Over the past 52 weeks the stock has ranged between $33.27 and $60.89, and currently trades 40.2% below its 52-week high.
On profitability, KEQU generates a return on equity (ROE) of 17.19%, above the typical market average, return on capital employed of 26.87%, an operating margin of 7.50%, a net profit margin of 3.85%.